会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • IMMUNE BALANCE REGULATOR
    • 免费平衡调节器
    • US20170020939A1
    • 2017-01-26
    • US15302300
    • 2015-04-08
    • euglena Co., Ltd.
    • Ayaka NAKASHIMAYuta ASAYAMAEriko YOSHIDAOsamu IWATAKengo SUZUKI
    • A61K36/02A23L33/10A61K31/715
    • A61K36/02A23L33/10A23L33/105A23V2002/00A61K31/715A61K31/716C12N1/10
    • The present invention provides a novel immune balance regulator that regulates an immune balance in a living body. The immune balance regulator contains a Euglena-derived material and regulates an immune balance between Th1, Th2, and Th17, which is a balance between immune responses individually induced by Th1, Th2, and Th17 in a living body. The immune balance regulator regulates the immune balance between Th1, Th2, and Th17 so that immune responses induced by Th1 become relatively dominant over immune responses induced by Th2 or Th17 to improve a physical constitution that has an immune imbalance of Th1, Th2, and Th17 shifted towards Th2 and to prevent or treat a disease associated with the immune imbalance of Th1, Th2, and Th17 shifted towards a Th2 dominance. The immune balance regulator is administered prior to expected onset of a disease associated with the immune imbalance of Th1, Th2, and Th17 shifted towards the Th2 dominance.
    • 本发明提供了调节活体免疫平衡的新型免疫平衡调节剂。 免疫平衡调节物含有来自Euglena的材料并调节Th1,Th2和Th17之间的免疫平衡,Th1,Th2和Th17是活体中Th1,Th2和Th17单独诱导的免疫反应之间的平衡。 免疫平衡调节因子调节Th1,Th2和Th17之间的免疫平衡,使Th1诱导的免疫反应相对于由Th2或Th17诱导的免疫应答相对优势,以改善具有Th1,Th2和Th17免疫失衡的物理结构 转移到Th2,并预防或治疗与Th1,Th2和Th17的免疫不平衡相关的疾病向Th2优势转移。 免疫平衡调节剂在预期发生与Th1,Th2和Th17的免疫失衡相关的疾病之前施用,向Th2优势移动。